Skip to Content

Moderna to Request Emergency Use Authorization for COVID-19 Vaccine

MONDAY, Nov. 30, 2020 -- Moderna said it would apply on Monday for emergency use authorization of its COVID-19 vaccine and the first shots could be given as early as Dec. 21, The New York Times reported.

Moderna's application is based on data showing that its vaccine is 94.1 percent effective and that its study of 30,000 people has met the scientific criteria needed to determine whether the vaccine works. The finding from the complete set of data is in line with earlier data that showed the vaccine to be 94.5 percent effective, The Times said.

Additionally, the vaccine was 100 percent effective at preventing severe disease from COVID-19, Moderna officials said. The product was developed in collaboration with government researchers from the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases.

The company is "on track" to produce 20 million doses by the end of December and 500 million to 1 billion in 2021, the newspaper reported. Each person requires two doses, administered a month apart, so 20 million doses will be enough for 10 million people.

Earlier this month, Pfizer asked the U.S. Food and Drug Administration for the same emergency use approval. Pfizer has said it can produce up to 50 million doses this year, with about half going to the United States, The Times reported. Its vaccine also requires two doses per person.

The New York Times Article

© 2021 HealthDay. All rights reserved.

Posted: November 2020

Read this next

COVID-19 Vaccine Likely Safe for Lactating Women

TUESDAY, Jan. 19, 2021 -- Women should not stop breastfeeding in order to get a COVID-19 vaccine, according to a statement released by the Academy of Breastfeeding Medicine and...

IgG Level in Convalescent Plasma Affects COVID-19 Death Risk

TUESDAY, Jan. 19, 2021 -- For patients hospitalized with COVID-19 and not receiving mechanical ventilation, the risk for death is reduced with transfusion of plasma with higher...

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 11 to 15, 2021. This roundup...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.